ASSEMBLY KIT FOR PREPARING OF A PRE-FILLED SYRINGE
    3.
    发明申请
    ASSEMBLY KIT FOR PREPARING OF A PRE-FILLED SYRINGE 审中-公开
    用于准备预填充的SYRINGE的组装工具包

    公开(公告)号:US20120259288A1

    公开(公告)日:2012-10-11

    申请号:US13391734

    申请日:2010-08-26

    IPC分类号: A61M5/28 A61M5/315 B23P11/00

    摘要: The present invention relates to an assembly kit for preparing of a pre-filled syringe and in particular to a method of preparing of such pre-filled syringe assemblies by means of an assembly kit, wherein the assembly kit comprises: a gripping means to be attached to a proximal end section of a cartridge which comprises an axially displaceable bung for sealing of an interior volume of the cartridge being pre-filled with an injectable medicinal product, a needle mount to be attached to a distal end section of the cartridge and providing a mount for a needle assembly to be coupled to the interior volume of the cartridge in a fluid-transferring way, a plunger rod connectable with the bung of the cartridge for applying distally directed thrust to the bung, wherein the cartridge is at least partially embedded in a protecting sleeve.

    摘要翻译: 本发明涉及一种用于制备预填充注射器的装配套件,特别涉及一种借助于组装套件制备这种预装注射器组件的方法,其中组装套件包括:待附接的夹持装置 到药筒的近端部分,其包括用于密封预先填充有可注射药用产品的药筒的内部容积的可轴向移位的栓,待附接到药筒的远端部分的针座, 针组件以流体传递的方式联接到药筒的内部容积;柱塞杆,其可与药筒的栓连接,用于将远端指向的推力施加到栓塞上,其中药筒至少部分地嵌入 保护套

    AQUEOUS PHARMACEUTICAL FORMULATION OF 4-[((4-CARBOXYBUTYL)-AMINO)METHYL]BENZOIC ACID
    7.
    发明申请
    AQUEOUS PHARMACEUTICAL FORMULATION OF 4-[((4-CARBOXYBUTYL)-AMINO)METHYL]BENZOIC ACID 审中-公开
    4 - [((4-羧甲基) - 氨基)甲基]苯甲酸的水性药物制剂

    公开(公告)号:US20100069493A1

    公开(公告)日:2010-03-18

    申请号:US12307452

    申请日:2007-06-26

    IPC分类号: A61K31/195

    摘要: The present invention relates to an aqueous pharmaceutical formulation which comprises 4-[((4-carboxybutyl)-{2-[(4-phenethylbenzyl)oxy]phenethyl}amino)methyl]benzoic acid or a salt thereof. The present invention relates in particular to an aqueous pharmaceutical formulation which comprises 4-[((4-carboxybutyl)-{2-[(4-phenethylbenzyl)oxy]phenethyl}amino)methyl]benzoic acid and 2-amino-2-(hydroxymethyl)-1,3-propanediol (trometamol).

    摘要翻译: 本发明涉及含有4 - [((4-羧丁基) - {2 - [(4-苯乙基苄基)氧基]苯乙基}氨基)甲基]苯甲酸或其盐的含水药物制剂。 本发明特别涉及含有4 - [((4-羧丁基) - {2 - [(4-苯乙基苄基)氧基]苯乙基}氨基)甲基]苯甲酸和2-氨基-2-( 羟甲基)-1,3-丙二醇(氨甲磺酸)。

    OTAMIXABAN FORMULATIONS WITH IMPROVED STABILITY
    8.
    发明申请
    OTAMIXABAN FORMULATIONS WITH IMPROVED STABILITY 审中-公开
    具有改善稳定性的OTAMIXABAN配方

    公开(公告)号:US20120252852A1

    公开(公告)日:2012-10-04

    申请号:US13431571

    申请日:2012-03-27

    摘要: The invention relates to a pharmaceutical composition comprising methyl (2R,3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino}butanoate or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable acidic reacting compound or to an aqueous solution or dispersion of the composition as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from conditions which can be ameliorated by the administration of an inhibitor of Factor Xa.

    摘要翻译: 本发明涉及包含(2R,3R)-2- {3- [氨基(亚氨基)甲基]苄基} -3 - {[4-(1-氧化吡啶-4-基)苯甲酰基]氨基}丁酸甲酯 或其药学上可接受的盐和药学上可接受的酸性反应化合物或该组合物的水溶液或分散体及其制备方法,使用该组合物治疗患有可被改善的病症的受试者的方法 通过施用因子Xa的抑制剂。